Clinical Trials in Philadelphia

Showing 11001-11020 of 20,904 trials

Development and Initial Tests of Reward Re-Training: A Novel Treatment For Reward Dysfunction

NCT03942874

The purpose of this study is to test a novel treatment for binge eating that will be compared to a waitlist control group. The investigators are seeking to target factors that might influence binge eating by increasing reward in non-food life domains. The treatment is weekly for 10 weeks and will take place at Drexel University in Philadelphia.

Binge EatingBinge-Eating DisorderBulimia Nervosa

Drexel University19 participantsStarted Apr 2019

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 3< 1 mile

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

NCT02952586

This is a phase 3 randomized, placebo controlled study to evaluate the safety and anti-tumor activity of Avelumab in combination with standard of care chemoradiation (SoC CRT) versus SoC CRT alone in front-line treatment of patients with locally advanced head and neck cancer.

Squamous Cell Carcinoma of the Head and Neck

Pfizer697 participantsStarted Nov 2016

Fayetteville, Arkansas, United States • Rogers, Arkansas, United States • Springdale, Arkansas, United States +313 more locations

Development and Initial Tests of Reward Re-Training: A Novel Treatment For Reward Dysfunction

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Find Trials by Condition in Philadelphia

A Cohort Study of Operationally Tolerant Allograft Recipients

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure

Behavioral Economics and Mobility After Stroke (BE Mobile)

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Enzalutamide Before Surgery in Treating Patients With Kidney Cancer

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

First in Human Study for Safety and Tolerability of AL003.

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

The International Polycap Study 3 (TIPS-3)

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)